MedTrace Logo

Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery

NCT04449783 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-07-20

No results posted yet for this study

Summary

trial to assess the effectiveness of pre-operative screening for COVID-19 in patients undergoing elective cancer surgery.

Conditions

Interventions

OTHER

pre-operative screening

reported symptoms plus nose and throat swabbing 48 hrs prior to surgery

OTHER

telephone consult

telephone consult 14 days (+/- 2 days) to assess for any COVID-19 symptoms

Sponsors & Collaborators

  • Liverpool University Hospitals NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Robert Jones, MBChB · Liverpool University Hospitals NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-25
Primary Completion
2020-08-25
Completion
2020-09-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04449783 on ClinicalTrials.gov